Open Access

Science

, том 375 , издание 6576 , страницы 43-50

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Тип публикации: Journal Article

Дата публикации: 2022-01-07

American Association for the Advancement of Science (AAAS)

Science

SCImago Q1

Tоп 10% SCImago

WOS Q1

БС1

SJR: 10.948

CiteScore: 44.6

Impact factor: 47.3

ISSN: 00368075, 10959203

DOI: 10.1126/science.abm3425

Скопировать DOI

PubMed ID: 34812653

Multidisciplinary

Краткое описание

Antibody levels predict vaccine efficacy

Symptomatic COVID-19 infection can be prevented by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. A “correlate of protection” is a molecular biomarker to measure how much immunity is needed to fight infection and is key for successful global immunization programs. Gilbert et al . determined that antibodies are the correlate of protection in vaccinated individuals enrolled in the Moderna COVE phase 3 clinical trial (see the Perspective by Openshaw). By measuring binding and neutralizing antibodies against the viral spike protein, the authors found that the levels of both antibodies correlated with the degree of vaccine efficacy. The higher the antibody level, the greater the protection afforded by the messenger RNA (mRNA) vaccine. Antibody levels that predict mRNA vaccine efficacy can therefore be used to guide vaccine regimen modifications and support regulatory approvals for a broader spectrum of the population. —PNK

Для доступа к списку цитирований публикации необходимо авторизоваться.

Войти с ORCID

Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Войти с ORCID

Топ-30

Журналы

	20 40 60 80 100 120
medRxiv	medRxiv, 107, 10.65% medRxiv 107 публикаций, 10.65%
Vaccines	Vaccines, 47, 4.68% Vaccines 47 публикаций, 4.68%
Vaccine	Vaccine, 43, 4.28% Vaccine 43 публикации, 4.28%
bioRxiv	bioRxiv, 43, 4.28% bioRxiv 43 публикации, 4.28%
Frontiers in Immunology	Frontiers in Immunology, 39, 3.88% Frontiers in Immunology 39 публикаций, 3.88%
Nature Communications	Nature Communications, 39, 3.88% Nature Communications 39 публикаций, 3.88%
Journal of Infectious Diseases	Journal of Infectious Diseases, 23, 2.29% Journal of Infectious Diseases 23 публикации, 2.29%
npj Vaccines	npj Vaccines, 22, 2.19% npj Vaccines 22 публикации, 2.19%
Scientific Reports	Scientific Reports, 19, 1.89% Scientific Reports 19 публикаций, 1.89%
Clinical Infectious Diseases	Clinical Infectious Diseases, 16, 1.59% Clinical Infectious Diseases 16 публикаций, 1.59%
iScience	iScience, 14, 1.39% iScience 14 публикаций, 1.39%
Journal of Medical Virology	Journal of Medical Virology, 14, 1.39% Journal of Medical Virology 14 публикаций, 1.39%
Viruses	Viruses, 13, 1.29% Viruses 13 публикаций, 1.29%
Nature Medicine	Nature Medicine, 13, 1.29% Nature Medicine 13 публикаций, 1.29%
EBioMedicine	EBioMedicine, 13, 1.29% EBioMedicine 13 публикаций, 1.29%
Open Forum Infectious Diseases	Open Forum Infectious Diseases, 13, 1.29% Open Forum Infectious Diseases 13 публикаций, 1.29%
Human Vaccines and Immunotherapeutics	Human Vaccines and Immunotherapeutics, 13, 1.29% Human Vaccines and Immunotherapeutics 13 публикаций, 1.29%
Cell Reports Medicine	Cell Reports Medicine, 11, 1.09% Cell Reports Medicine 11 публикаций, 1.09%
Cell	Cell, 11, 1.09% Cell 11 публикаций, 1.09%
Science Translational Medicine	Science Translational Medicine, 10, 1% Science Translational Medicine 10 публикаций, 1%
PLoS ONE	PLoS ONE, 9, 0.9% PLoS ONE 9 публикаций, 0.9%
Microbiology spectrum	Microbiology spectrum, 9, 0.9% Microbiology spectrum 9 публикаций, 0.9%
Cell Reports	Cell Reports, 8, 0.8% Cell Reports 8 публикаций, 0.8%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 7, 0.7% International Journal of Molecular Sciences 7 публикаций, 0.7%
Nature Immunology	Nature Immunology, 7, 0.7% Nature Immunology 7 публикаций, 0.7%
Communications Medicine	Communications Medicine, 7, 0.7% Communications Medicine 7 публикаций, 0.7%
New England Journal of Medicine	New England Journal of Medicine, 6, 0.6% New England Journal of Medicine 6 публикаций, 0.6%
Influenza and other Respiratory Viruses	Influenza and other Respiratory Viruses, 6, 0.6% Influenza and other Respiratory Viruses 6 публикаций, 0.6%
EClinicalMedicine	EClinicalMedicine, 6, 0.6% EClinicalMedicine 6 публикаций, 0.6%
	20 40 60 80 100 120

Издатели

	50 100 150 200 250
Elsevier	Elsevier, 221, 21.99% Elsevier 221 публикация, 21.99%
Springer Nature	Springer Nature, 176, 17.51% Springer Nature 176 публикаций, 17.51%
openRxiv	openRxiv, 150, 14.93% openRxiv 150 публикаций, 14.93%
MDPI	MDPI, 91, 9.05% MDPI 91 публикация, 9.05%
Wiley	Wiley, 66, 6.57% Wiley 66 публикаций, 6.57%
Oxford University Press	Oxford University Press, 64, 6.37% Oxford University Press 64 публикации, 6.37%
Frontiers Media S.A.	Frontiers Media S.A., 51, 5.07% Frontiers Media S.A. 51 публикация, 5.07%
Taylor & Francis	Taylor & Francis, 24, 2.39% Taylor & Francis 24 публикации, 2.39%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 21, 2.09% American Association for the Advancement of Science (AAAS) 21 публикация, 2.09%
American Society for Microbiology	American Society for Microbiology, 19, 1.89% American Society for Microbiology 19 публикаций, 1.89%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 17, 1.69% Public Library of Science (PLoS) 17 публикаций, 1.69%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 15, 1.49% Ovid Technologies (Wolters Kluwer Health) 15 публикаций, 1.49%
BMJ	BMJ, 11, 1.09% BMJ 11 публикаций, 1.09%
American Society for Clinical Investigation	American Society for Clinical Investigation, 6, 0.6% American Society for Clinical Investigation 6 публикаций, 0.6%
Massachusetts Medical Society	Massachusetts Medical Society, 6, 0.6% Massachusetts Medical Society 6 публикаций, 0.6%
American Medical Association (AMA)	American Medical Association (AMA), 5, 0.5% American Medical Association (AMA) 5 публикаций, 0.5%
American College of Physicians	American College of Physicians, 3, 0.3% American College of Physicians 3 публикации, 0.3%
Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC), 3, 0.3% Centers for Disease Control and Prevention (CDC) 3 публикации, 0.3%
SAGE	SAGE, 3, 0.3% SAGE 3 публикации, 0.3%
eLife Sciences Publications	eLife Sciences Publications, 3, 0.3% eLife Sciences Publications 3 публикации, 0.3%
De Gruyter Brill	De Gruyter Brill, 3, 0.3% De Gruyter Brill 3 публикации, 0.3%
Research Square Platform LLC	Research Square Platform LLC, 3, 0.3% Research Square Platform LLC 3 публикации, 0.3%
Georg Thieme Verlag KG	Georg Thieme Verlag KG, 2, 0.2% Georg Thieme Verlag KG 2 публикации, 0.2%
Annual Reviews	Annual Reviews, 2, 0.2% Annual Reviews 2 публикации, 0.2%
American Association for Cancer Research (AACR)	American Association for Cancer Research (AACR), 2, 0.2% American Association for Cancer Research (AACR) 2 публикации, 0.2%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 2, 0.2% Bentham Science Publishers Ltd. 2 публикации, 0.2%
American Academy of Pediatrics	American Academy of Pediatrics, 2, 0.2% American Academy of Pediatrics 2 публикации, 0.2%
The American Association of Immunologists	The American Association of Immunologists, 2, 0.2% The American Association of Immunologists 2 публикации, 0.2%
Institute of Electrical and Electronics Engineers (IEEE)	Institute of Electrical and Electronics Engineers (IEEE), 2, 0.2% Institute of Electrical and Electronics Engineers (IEEE) 2 публикации, 0.2%
	50 100 150 200 250

Мы не учитываем публикации, у которых нет DOI.
Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.

Войти с ORCID

PDF

Метрики

Цитировать

ГОСТ |

Цитировать

ГОСТ Скопировать

Gilbert P. G. et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial // Science. 2022. Vol. 375. No. 6576. pp. 43-50.

ГОСТ со всеми авторами (до 50) Скопировать

Gilbert P. G., Montefiori D. C., McDermott A. B., Fong Y., Benkeser D., Deng W., Zhou H., Houchens C. R., Martins K. J., Jayashankar L., Castellino F., Flach B., Lin B. C., O’Connell S., McDanal C., Eaton A. J., Sarzotti-Kelsoe M., Lu Y., Yu C., Borate B., van der Laan L. W. P., Hejazi N. S., Chuong H., Miller J., El Sahly H. M., Baden L. R., Baron M., de la Cruz L., Gay C., Kalams S., Kelley C. F., Andrasik M. P., Kublin J. G., Corey L., Neuzil K. M., Carpp L. N., Pajon R., Follmann D., Donis R. O., Koup R. A. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial // Science. 2022. Vol. 375. No. 6576. pp. 43-50.

RIS |

Цитировать

RIS Скопировать

TY - JOUR

DO - 10.1126/science.abm3425

UR - https://doi.org/10.1126/science.abm3425

TI - Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

T2 - Science

AU - Gilbert, Peter G.

AU - Montefiori, David C.

AU - McDermott, Adrian B.

AU - Fong, Youyi

AU - Benkeser, David

AU - Deng, Weiping

AU - Zhou, Honghong

AU - Houchens, Christopher R

AU - Martins, Karen J.B.

AU - Jayashankar, Lakshmi

AU - Castellino, Flora

AU - Flach, Britta

AU - Lin, Bob C

AU - O’Connell, Sarah

AU - McDanal, Charlene

AU - Eaton, Amanda J.

AU - Sarzotti-Kelsoe, Marcella

AU - Lu, Yiwen

AU - Yu, Chenchen

AU - Borate, Bhavesh

AU - van der Laan, Lars W. P.

AU - Hejazi, Nima S.

AU - Chuong, Huynh

AU - Miller, Jacqueline

AU - El Sahly, Hana M

AU - Baden, Lindsey R.

AU - Baron, Mira

AU - de la Cruz, Luis

AU - Gay, Cynthia

AU - Kalams, Spyros

AU - Kelley, Colleen F.

AU - Andrasik, Michele P

AU - Kublin, James G

AU - Corey, Lawrence

AU - Neuzil, Kathleen M.

AU - Carpp, Lindsay N.

AU - Pajon, Rolando

AU - Follmann, Dean

AU - Donis, Ruben O

AU - Koup, Richard A.

PY - 2022

DA - 2022/01/07

PB - American Association for the Advancement of Science (AAAS)

SP - 43-50

IS - 6576

VL - 375

PMID - 34812653

SN - 0036-8075

SN - 1095-9203

ER -

BibTex |

Цитировать

BibTex (до 50 авторов) Скопировать

@article{2022_Gilbert,

author = {Peter G. Gilbert and David C. Montefiori and Adrian B. McDermott and Youyi Fong and David Benkeser and Weiping Deng and Honghong Zhou and Christopher R Houchens and Karen J.B. Martins and Lakshmi Jayashankar and Flora Castellino and Britta Flach and Bob C Lin and Sarah O’Connell and Charlene McDanal and Amanda J. Eaton and Marcella Sarzotti-Kelsoe and Yiwen Lu and Chenchen Yu and Bhavesh Borate and Lars W. P. van der Laan and Nima S. Hejazi and Huynh Chuong and Jacqueline Miller and Hana M El Sahly and Lindsey R. Baden and Mira Baron and Luis de la Cruz and Cynthia Gay and Spyros Kalams and Colleen F. Kelley and Michele P Andrasik and James G Kublin and Lawrence Corey and Kathleen M. Neuzil and Lindsay N. Carpp and Rolando Pajon and Dean Follmann and Ruben O Donis and Richard A. Koup},

title = {Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial},

journal = {Science},

year = {2022},

volume = {375},

publisher = {American Association for the Advancement of Science (AAAS)},

month = {jan},

url = {https://doi.org/10.1126/science.abm3425},

number = {6576},

pages = {43--50},

doi = {10.1126/science.abm3425}

}

MLA

Цитировать

MLA Скопировать

Gilbert, Peter G., et al. “Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.” Science, vol. 375, no. 6576, Jan. 2022, pp. 43-50. https://doi.org/10.1126/science.abm3425.

Издатель

American Association for the Advancement of Science (AAAS)

Журнал

Science

SCImago Q1

Tоп 10% SCImago

WOS Q1

БС1